Ownership Summary
RAPT Therapeutics, Inc. (NASDAQ:RAPT) appears in 3 institutional 13F filings for the quarter ending December 2025.
- Collectively, these holders controlled 11.0% of RAPT Therapeutics's outstanding shares in December 2025, down from 11.0% in September 2025.
- Their total shares held in RAPT decreased -0.33% from the prior quarter, while the number of investors in RAPT Therapeutics decreased 96.7% year over year.
- Among the 3 funds, 0 bought more RAPT Therapeutics shares, 1 sold down, and 2 held their ground.
- Combined, these investors held 2.96Mn shares in RAPT for December 2025, down by 9.8K shares quarter on quarter, and down 124.81Mn shares year over year.
- Medicxi Ventures Management (Jersey) Ltd is the top holder of RAPT Therapeutics as of December 31, 2025, with 2.79Mn shares representing 10.36% of outstanding stock.
- Leading sellers of RAPT Therapeutics shares for the quarter ending December 2025 were Column Group LLC (9.8K).
- RAPT Therapeutics's 3 largest shareholders as of December 2025 include Medicxi Ventures Management (Jersey) Ltd (2.79Mn), Column Group LLC (156.27K), AJU IB Investment Co., Ltd. (12.44K) per Business Quant data.